High Tower Advisors, LLC Gilead Sciences, Inc. Transaction History

High Tower Advisors, LLC

$68.3 Billion
Q3 2024

A detailed history of High Tower Advisors, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, High Tower Advisors, LLC holds 1,780,953 shares of GILD stock, worth $162 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares

1,780,953

Previous 1,625,930 9.53%

Holding current value

$162 Million

Previous $112 Million 33.82%

% of portfolio

0.22%

Previous 0.17%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$66.59 - $83.99 $10.3 Million - $13 Million	155,023 Added 9.53%	1,780,953 $149 Million
Q2 2024 Aug 13, 2024	BUY	$63.15 - $72.88 $16.9 Million - $19.5 Million	268,032 Added 19.74%	1,625,930 $112 Million
Q1 2024 May 06, 2024	BUY	$71.58 - $87.29 $10.7 Million - $13.1 Million	149,560 Added 12.38%	1,357,898 $99.5 Million
Q4 2023 Feb 12, 2024	BUY	$73.27 - $83.09 $2.87 Million - $3.26 Million	39,212 Added 3.35%	1,208,338 $97.9 Million
Q3 2023 Nov 08, 2023	BUY	$73.94 - $80.67 $5.74 Million - $6.26 Million	77,653 Added 7.11%	1,169,126 $87.6 Million
Q2 2023 Aug 14, 2023	BUY	$76.01 - $86.7 $2.4 Million - $2.74 Million	31,599 Added 2.98%	1,091,473 $84.1 Million
Q1 2023 May 11, 2023	SELL	$77.31 - $88.08 $20.5 Million - $23.3 Million	-264,803 Reduced 19.99%	1,059,874 $87.9 Million
Q4 2022 Feb 08, 2023	BUY	$62.32 - $89.47 $12.2 Million - $17.6 Million	196,260 Added 17.39%	1,324,677 $114 Million
Q3 2022 Nov 09, 2022	BUY	$59.54 - $68.01 $3.45 Million - $3.94 Million	57,949 Added 5.41%	1,128,417 $69.6 Million
Q2 2022 Aug 10, 2022	BUY	$57.72 - $65.01 $6.04 Million - $6.8 Million	104,664 Added 10.84%	1,070,468 $66.1 Million
Q1 2022 May 12, 2022	BUY	$57.92 - $72.58 $4.69 Million - $5.88 Million	80,969 Added 9.15%	965,804 $57.4 Million
Q4 2021 Feb 10, 2022	BUY	$64.88 - $73.64 $3.42 Million - $3.88 Million	52,755 Added 6.34%	884,835 $64.2 Million
Q3 2021 Nov 12, 2021	BUY	$67.69 - $73.03 $3.43 Million - $3.7 Million	50,703 Added 6.49%	832,080 $58.1 Million
Q2 2021 Aug 06, 2021	BUY	$63.47 - $69.35 $3.61 Million - $3.94 Million	56,845 Added 7.85%	781,377 $53.8 Million
Q1 2021 May 10, 2021	BUY	$60.0 - $68.46 $8.83 Million - $10.1 Million	147,189 Added 25.49%	724,532 $46.8 Million
Q4 2020 Feb 10, 2021	SELL	$56.65 - $64.55 $6.73 Million - $7.67 Million	-118,811 Reduced 17.07%	577,343 $33.7 Million
Q3 2020 Nov 13, 2020	BUY	$62.1 - $78.08 $4.34 Million - $5.45 Million	69,814 Added 11.15%	696,154 $44 Million
Q2 2020 Aug 10, 2020	BUY	$72.34 - $84.0 $2.67 Million - $3.11 Million	36,965 Added 6.27%	626,340 $48.3 Million
Q1 2020 May 21, 2020	BUY	$62.63 - $80.22 $3.83 Million - $4.9 Million	61,107 Added 11.57%	589,375 $44 Million
Q4 2019 Feb 14, 2020	BUY	$61.62 - $67.78 $6.64 Million - $7.3 Million	107,761 Added 25.63%	528,268 $34.3 Million
Q3 2019 Nov 12, 2019	BUY	$62.51 - $69.0 $743,243 - $820,410	11,890 Added 2.91%	420,507 $26.7 Million
Q2 2019 Aug 13, 2019	BUY	$61.87 - $69.38 $1.75 Million - $1.96 Million	28,263 Added 7.43%	408,617 $27.6 Million
Q1 2019 May 15, 2019	SELL	$62.53 - $70.05 $902,120 - $1.01 Million	-14,427 Reduced 3.65%	380,354 $24.8 Million
Q4 2018 Feb 14, 2019	SELL	$60.54 - $79.0 $3.43 Million - $4.48 Million	-56,659 Reduced 12.55%	394,781 $24.8 Million
Q3 2018 Nov 09, 2018	BUY	$71.28 - $78.92 $3.66 Million - $4.06 Million	51,400 Added 12.85%	451,440 $34.9 Million
Q2 2018 Aug 14, 2018	SELL	$64.88 - $75.68 $359,240 - $419,040	-5,537 Reduced 1.37%	400,040 $28.3 Million
Q1 2018 May 15, 2018	SELL	$72.84 - $88.8 $1.56 Million - $1.9 Million	-21,355 Reduced 5.0%	405,577 $30.6 Million
Q4 2017 Feb 14, 2018	SELL	$71.15 - $83.52 $3.52 Million - $4.13 Million	-49,458 Reduced 10.38%	426,932 $30.6 Million
Q3 2017 Nov 14, 2017	BUY	$72.11 - $85.47 $8.27 Million - $9.81 Million	114,730 Added 31.72%	476,390 $38.6 Million
Q2 2017 Aug 14, 2017	BUY	N/A	361,660	361,660 $25.6 Million

Others Institutions Holding GILD

# of Institutions

1,930

Shares Held

992M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $114B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Tower Advisors, LLC with notifications on news.

Account

High Tower Advisors, LLC Gilead Sciences, Inc. Transaction History